Clinical trials (Patients)

CYDEPS – Dose escalation pain study – Recruitment to commence in August 2021

The CYDEPS clinical trial is investigating the use of a medical cannabis product as a potential

treatment for chronic back and/or neck pain.

The study is a single arm, open label clinical study which means everyone who participates will

receive the experimental medication (there is no placebo).

The clinical study will run for approximately 5-6 weeks, and will include 8 study visits to a medical

clinic over this time, each time seeing the study doctor. The clinical study is open to eligible

participants in Sydney.

TO BE ELIGIBLE YOU MUST:

– Be aged 18-75

– Have a history of chronic neck and/or back pain for at least 3 months

– Tried treatment with over the counter (OTC) treatments such as paracetamol and ibuprofen which haven’t worked

FURTHER DETAILS ARE AVAILABLE AT:

www.clinicaltrials.gov

ClinicalTrials.gov Identifier: NCT04976738

https://clinicaltrials.gov/ct2/show/NCT04976738?term=cymra&draw=2&rank=1#contacts